Lumbar disc herniation, chronic low back pain, sciatica. Lumbago with sciatica, unspecified side
Conditions
Interventions
Intervention 1: Intervention group: In the high-power laser intervention group, high-power laser treatment patients will receive high-power laser from the device manufactured by Novin Company. The dev
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 60 years They signed informed consent forms and volunteered to participate in the experiments They have had back pain for more than 3 months On examination they have local sensitivity in the back, buttocks and legs, and shooting pain, and they have a Straight Leg Rising (SLR) test or a Slump test MRI of the lumbar disc herniation was seen Have the mental ability to answer questionnaire questions
Exclusion criteria
Exclusion criteria: Acute trauma or fracture of the lumbar spine or dysplasia of the spinal structure (spondylolysis) Congenital anomaly, abdominal aneurysm 3. Lumbar spine surgery Uncontrolled or severe metabolic disorders or cardiovascular, hepatic and renal disorders Lumbar spine surgery Uncontrolled or severe metabolic disorders or cardiovascular, hepatic and renal disorders Inflammatory pain Severe or progressive neurological disorders or lumbar instability Physiotherapy treatments on the back in the last 3 months History of lumbar injection in the last 4 weeks Severe osteopenia Systemic rheumatic disease (rheumatoid arthritis and fibromyalgia) Spinal cancers and patients with spinal tuberculosis Danger symptoms include nocturnal pain, recent involuntary weight loss, and symptoms of Cauda equina syndrome Spondylolisthesis Hypersensitivity to piroxicam and methocarbamol Patients who have undergone lumbar spine fusion or have indication for surgery Pregnant patients Patients who have had a tattoo or melanocytic moles in or near the treatment areas Patients with lupus or any other autoimmune disease, thrombophlebitis or anemia, and skin allergies Not participating in treatment sessions for more than 2 sessions Dissatisfaction with participating in the study at any stage of the study No referral for follow-up 4 weeks later and no phone response 3 months after starting treatment Emergence of severe medical diseases during the study that affect the individual's referral and follow-up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity, quality of life, degree of disability in patients with chronic low back pain. Timepoint: Initially studied, 4 weeks and three months after starting treatment. Method of measurement: McGill Pain Questionnaire ,Oswestry Low Back Pain Disability Questionnaire, WHO Quality of Life, Visual Analogue Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahin Safari
Mazandaran University of Medical Sciences
Outcome results
None listed